Nkarta Inc (NKTX)
2.355
-0.06
(-2.69%)
USD |
NASDAQ |
Jan 08, 12:50
Nkarta Research and Development Expense (Annual): 96.77M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| AMN Healthcare Services Inc | -- |
| Moderna Inc | 4.845B |
| CEL-SCI Corp | 22.47M |
| AIM ImmunoTech Inc | 10.94M |
| IGC Pharma Inc | 3.773M |